← Evidence map

ReviewCancers2026

The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges.

Tancredi Didier Bazan Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges. | OpenQuestion